Premature Ejaculation Treatment Market Research Report by globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Noida: Families of COVID patients touch feet of CMO, ask for Remdesivir ANI | Updated: Apr 28, 2021 10:18 IST
Gautam Buddh Nagar (Uttar Pradesh) [India], April 28 (ANI): Amid the shortage of medical supplies due to the worrying rise in COVID-19 cases, families of COVID-19 patients in Noida were seen touching the feet of the Chief Medical Officer asking for essential medicines.
In the video that made rounds on the internet, relatives were seen touching the feet of CMO Deepak Ohri, requesting that they be provided with the anti-viral drug Remdesivir.
As per the union health ministry, there are currently 3,04,199 active COVID-19 cases in Uttar Pradesh, one of the highest in the country.
Pune pharmacist arrested for black marketing of Remdesivir injections aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
The import of Remdesivir Active Pharmaceutical Ingredients (API), injections and specific inputs have been made import duty free till October 31 amid the ongoing surge in COVID-19 cases in the country. Taking to Twitter, the ministry of finance on Tuesday shared a notification that said that the central government has exempted Remdesivir Active Pharmaceutical Ingredients, Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir subject to the condition that the importer follows the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017 and Injection Remdesivir from the whole of the duty of customs leviable on their import into India.
Commerce and Industry Minister Piyush Goyal tweeted, In line with PM Narendra Modi`s priority to ensure affordable medical care for
COVID-19 patients, imports of Remdesivir API, injection and specific inputs have been made import duty free. This should increase supply and reduce cost thus providing relief to patients.
Amid the shortage of Remdesivir in the wake of a spike in COVID-19 infections in the country, seven major pharmaceutical companies have already reduced the maximum retail price (MRP) of the anti-viral drug.
As per the revised price of major brands of Remdesivir injection 100mg/Vial`, Cadila Healthcare Ltd`s REMDAC which was earlier available at Rs 2,800, has been reduced to Rs 899.